Gene News and Research

Latest Gene News and Research

Particular genetic variation in humans linked with blond hair

Particular genetic variation in humans linked with blond hair

Castle Biosciences reports study results from DecisionDx-EC multi-analyte test for esophageal cancer

Castle Biosciences reports study results from DecisionDx-EC multi-analyte test for esophageal cancer

New software tool helps identify genetic mutations linked to increased risk for cancer

New software tool helps identify genetic mutations linked to increased risk for cancer

Experts from ProfNet network available to discuss timely issues in coverage area

Experts from ProfNet network available to discuss timely issues in coverage area

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

Agena Bioscience expands ultrasensitive somatic mutation detection technology

Agena Bioscience expands ultrasensitive somatic mutation detection technology

Compound in saliva and proteins in blood may protect human cells from powerful toxins in tea, coffee

Compound in saliva and proteins in blood may protect human cells from powerful toxins in tea, coffee

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

EKF, GILUPI report data on circulating tumour cell DNA enrichment, mutation detection

EKF, GILUPI report data on circulating tumour cell DNA enrichment, mutation detection

Gene regulation responsible for normal breast tissue may also play role in cancer development

Gene regulation responsible for normal breast tissue may also play role in cancer development

Researchers identify new therapeutic target for treating most common form of eye cancer

Researchers identify new therapeutic target for treating most common form of eye cancer

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

New insights into egg selection may have broad implications for women's health, fertility

New insights into egg selection may have broad implications for women's health, fertility

New research shows how misfolded proteins are precisely selected for degradation

New research shows how misfolded proteins are precisely selected for degradation

New powerful tool helps identify disease-causing mutations in families

New powerful tool helps identify disease-causing mutations in families

Study reveals how BTK mutation triggers drug resistance in CLL patients

Study reveals how BTK mutation triggers drug resistance in CLL patients

Researchers create initial catalog of human proteome, identify 193 novel proteins

Researchers create initial catalog of human proteome, identify 193 novel proteins

Initial biopsy with epigenetic test rules out prostate cancer up to 88%

Initial biopsy with epigenetic test rules out prostate cancer up to 88%

Researchers design commercial test to rule out presence of genetic biomarkers of prostate cancer

Researchers design commercial test to rule out presence of genetic biomarkers of prostate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.